By Elena Vardon

Tristel on Monday said its ULT high-level disinfectant has gotten approval by the U.S. Food and Drug Administration for its immediate sale for use on endocavity ultrasound probes and skin surface transducers.

The manufacturer of infection-prevention products said it will launch the product in the U.S. market in October. The group is working with Parker Laboratories and established a manufacturing base in New Jersey to make the disinfectant, which it will distribute using Parker's network for the ultrasound market.

Its DUO intermediate level disinfectant is now registered in all U.S. states, the London-listed group added.

Write to Elena Vardon at elena.vardon@wsj.com

(END) Dow Jones Newswires

June 05, 2023 03:04 ET (07:04 GMT)

Copyright (c) 2023 Dow Jones & Company, Inc.
Tristel (LSE:TSTL)
過去 株価チャート
から 4 2024 まで 5 2024 Tristelのチャートをもっと見るにはこちらをクリック
Tristel (LSE:TSTL)
過去 株価チャート
から 5 2023 まで 5 2024 Tristelのチャートをもっと見るにはこちらをクリック